Psoriasis on the face needs extra care. The skin is thin and sensitive, and the wrong product can cause problems of its own. This guide covers what trusted sources say about steroids, other prescription creams, over-the-counter options and sun protection, where those sources disagree, and what we looked for and could not find.
Why the face needs extra care
The National Psoriasis Foundation (NPF) says roughly half of people with psoriasis have it on the face, and that skin on and around the face is very sensitive and should be treated carefully.[1] A review of the American Academy of Dermatology (AAD) topical guidelines describes the face and skin folds as areas with thinner skin, and says lower-potency steroids are the better choice there to avoid adverse effects.[2]
That is why a product that suits an elbow or a knee is not automatically right for a cheek or an eyebrow. The rest of this article looks at each type of product and what the evidence says. Where we could not find a source for a common claim, we say so.
Where facial psoriasis shows up
The NPF says about 39% of people with facial psoriasis have it in or around the ears. It also says psoriasis around the eyes is rare but can cause redness or discoloration, dryness, discomfort and, in some cases, vision problems.[1] A type that overlaps with seborrheic dermatitis, called sebopsoriasis, shows as yellowish, greasy scale around the nasolabial folds (the lines from the nose to the corners of the mouth), the eyebrows and the forehead.[3] We did not find a source that ranks which facial spot is most common, so we do not rank them here.
Eyelids need a doctor. Cleveland Clinic lists tacrolimus ointment and corticosteroid creams as options for eyelid psoriasis, and warns that overuse or improper application around the eyelid can be dangerous to eyesight, with dry eye, cataracts and glaucoma named as risks. It advises talking with a dermatologist about frequent outbreaks around the eyes.[4] Do not put any new product on or near your eyelids without asking a doctor.
Steroids on the face: sources differ
Topical steroids are the most debated part of facial psoriasis care. The sources we opened give different advice.
"Topical steroids should not be used to treat psoriasis on the face."[1]
Lower-potency steroids are best on the face and skin folds. Taper over several weeks after improvement. No maximum duration is given.[2]
Weaker steroids such as 1% hydrocortisone can be used, but they carry a risk of skin thinning (atrophy) and "should only be used on an intermittent basis."[5]
Topical steroids should not be used on the face except for very short periods, under two weeks for prescribers, and patients should limit facial use to two weeks or less.[6]
These sources differ in date, country and audience, and we cannot tell you which is right for you. What they share is a concern about side effects. Medsafe lists skin thinning, visible small blood vessels (telangiectasia), dermatitis around the mouth (perioral dermatitis) and rosacea flares as effects reported with facial steroid use.[6] DermNet, a dermatology reference page that shows no author or date, says only mild to moderate potency steroids are appropriate for the face and skin folds.[3]
If a doctor prescribed a steroid for your face, follow their directions. Never stop or change a prescribed medication without talking to your doctor. Do not use a steroid prescribed for your body on your face unless a doctor says to.
Other prescription creams
Tacrolimus and pimecrolimus
The AAD says these medicines can treat plaque psoriasis on the face and other delicate areas, and inverse psoriasis in the armpits, groin and under the breasts. It also says the FDA approved them for eczema, not psoriasis, so doctors prescribe them off label, which the AAD calls "perfectly acceptable." The FDA has placed a warning on them about a possible higher risk of lymphoma or skin cancer, based on animal studies. The AAD says dermatologists have not seen an increase in these cancers in patients, and that the long-term safety of these medicines is unknown. It advises staying out of the sun and tanning beds while using them.[7]
The best trial evidence we found is for tacrolimus 0.1% ointment. A 2016 review reports a randomized trial of 167 people with facial and skin-fold psoriasis in which 65.2% were clear or almost clear, compared with 31.5% on placebo. Most other evidence in that review comes from small or open-label studies, and the review notes an inconsistency in the reported p-values for that trial.[8] The review had no efficacy data for pimecrolimus in psoriasis, and we did not find another source that did. UK primary care guidance describes tacrolimus 0.1% ointment as "the most effective treatment" for facial psoriasis.[5]
Newer non-steroid creams
Two newer prescription creams have been studied in the face or skin folds. Both studies were sponsored by the drug makers, and we read news reports of them rather than the full papers.
- Tapinarof 1% cream. A 12-week open-label study (no placebo group) in 31 adults with plaque psoriasis of the head and neck, where the face was the target area for 35.5% of people. The sponsor reported that 88.5% reached clear or almost clear skin by week 12. Reported side effects included contact dermatitis, folliculitis and headache.[9]
- Roflumilast 0.3% cream. A randomized phase 2b trial of 331 people with chronic plaque psoriasis, published in 2020. A subgroup of about 15% had psoriasis in skin folds, and more than 90% of that group were clear or almost clear at week 12 on the 0.3% dose, according to the trial's lead investigator and the sponsor.[10]
We did not find a randomized trial that was designed for the face in psoriasis. These are prescription medicines, so a dermatologist decides whether one fits you.
Over-the-counter ingredients
Salicylic acid
We looked for a strength of salicylic acid that is recommended for the face in psoriasis and did not find one. The AAFP review advises avoiding salicylic acid in people with kidney or liver impairment, or when the treated area is more than 20% of body surface.[2] Ask a doctor or pharmacist before using a salicylic acid product on your face.
Coal tar
Coal tar is an over-the-counter ingredient that helps temporarily relieve the itching, scaling, flaking, redness and irritation associated with psoriasis. We did not find a source that says how coal tar should be used on the face specifically. WebMD's product information for a coal tar shampoo says to avoid getting coal tar in the eyes, to talk to a provider first if you have very sensitive or allergic skin, and to stop use and contact a provider if symptoms do not improve or get worse.[11] That page is general product information, not Nopsor's label.
Niacinamide
Niacinamide (nicotinamide) is often named as a gentle ingredient. We found one small study of a nicotinamide gel: 48 people with eczema, contact dermatitis, atopic dermatitis or psoriasis used it for two weeks without a control group. The study did not report psoriasis results separately, and it was run by the gel's maker.[12] We cannot say from this whether niacinamide helps psoriasis, and we found no psoriasis-specific trial.
Moisturizer and daily care
The AAD advises moisturizing every day, using a lotion during the day for best results and a cream or ointment at bedtime.[13] We looked for evidence on which moisturizer ingredients suit facial psoriasis (ceramides, glycerin, hyaluronic acid) and on whether "non-comedogenic" formulas matter more on the face. We did not find sources that test these for psoriasis, so we do not rank ingredients.
Practical tip. Use lukewarm water and a gentle cleanser, pat the face dry, and moisturize soon after washing. This is general good practice, not a research finding. Your doctor's directions for any medicated product come first.
Practical tip. Before using a new product on a psoriasis patch, try a small amount on the jawline or behind the ear for a few days. If it stings, burns or causes a rash, stop and tell your doctor or pharmacist. This is general good practice, not a research finding.
Sun protection
The AAD says even a mild sunburn can worsen existing psoriasis and cause new patches to form.[13] On sunscreen, it advises SPF 30 or higher, broad-spectrum (UVA and UVB) protection and water resistance. For skin that stings or burns, it recommends a sunscreen containing only zinc oxide and titanium dioxide, and for sensitive skin it advises a label that says "sensitive skin" and avoiding fragrance, parabens and oxybenzone. Its page gives no reapplication interval, so follow the directions on the product you choose.[14]
Coal tar can make skin more sensitive to the sun for up to 24 hours, so use caution with sun exposure and use sunscreen on treated areas.[11] If you use tacrolimus or pimecrolimus, the AAD advises staying out of the sun.[7]
When to see a doctor
Facial psoriasis is a good reason for a dermatologist visit sooner rather than later, because the product choices are narrower and mistakes show. Consider an appointment if:
- psoriasis is on or around your eyelids, or your vision is affected[4]
- a medicated product is not helping or your skin gets worse. A coal tar product's information says to stop use and contact a provider in that case[11]
- you notice dermatitis around the mouth or eyes, redness, or prominent blood vessels on the cheeks while using a steroid. Medsafe says these signs mean the steroid should be stopped,[6] so contact your prescriber promptly rather than deciding alone
- you are not sure whether the patches are psoriasis or seborrheic dermatitis
- the way your face looks is affecting your mood or daily life
Sebopsoriasis
DermNet describes sebopsoriasis as an overlap between seborrheic dermatitis and psoriasis. Antifungal treatments are "very effective for seborrhoeic dermatitis but tend not to be helpful for psoriasis," so how much they help in sebopsoriasis varies. For the face and skin folds, the page says mild to moderate potency steroids are appropriate, and that tacrolimus ointment or pimecrolimus cream may help, especially for long-term treatment or when steroid side effects are a concern.[3]
Newer research on the seborrheic dermatitis side: a 2025 study followed 400 people aged 12 or older who used roflumilast foam 0.3% for up to 52 weeks. About 80% were clear or almost clear at week 52, but only 46 people reached that point, the study had no comparison group, and it was funded by the drug maker.[15] It studied seborrheic dermatitis, not psoriasis or sebopsoriasis.
Practical tip. If your facial patches look greasy or yellowish, say so at your appointment. It can help your doctor tell psoriasis from seborrheic dermatitis. This is general good practice, not a research finding. Only a doctor can diagnose which one you have.
Nopsor and your routine
Coal tar is an over-the-counter ingredient that helps temporarily relieve the itching, scaling, flaking, redness and irritation associated with psoriasis. Nopsor Body Wash & Shampoo has coal tar (2.2%) and salicylic acid as key ingredients, and Nopsor Deep Moisturizing Ointment has coal tar, salicylic acid and an 8-plant herbal blend. In the nightly routine, leave the wash on for about 3 minutes before rinsing, as the label directs, then apply the Ointment. Begin with a small area the first few nights, and stop and ask a doctor if irritation is severe or your skin gets worse. This article does not say Nopsor is meant for the face. Ask your doctor before using a coal tar product on the face, and follow the label. Coal tar can make skin more sensitive to the sun for up to 24 hours, so use caution with sun exposure and use sunscreen on treated areas. Never stop or change a prescribed medication without talking to your doctor.
Nopsor is not for children under 12 unless directed by a doctor.
References
- National Psoriasis Foundation. Psoriasis on the Face. Reviewed May 12, 2026 (medical reviewers G. Scott Drew, DO, and Tina Bhutani, MD). psoriasis.org
- American Family Physician. Psoriasis: Update on Topical Therapy From the American Academy of Dermatology. May 2022. aafp.org
- DermNet. Sebopsoriasis. No author or date shown on the page. dermnetnz.org
- Cleveland Clinic. Psoriasis on the Eyelids. Medically reviewed May 25, 2023. clevelandclinic.org
- Primary Care Dermatology Society (UK). Psoriasis: facial psoriasis. Last updated November 18, 2021 (UK guidance for primary care). pcds.org.uk
- Medsafe, New Zealand Medicines and Medical Devices Safety Authority. Prescriber Update article on topical corticosteroids on the face. December 2005 (older than the usual window; the page title was not shown when we opened it). medsafe.govt.nz
- American Academy of Dermatology. Psoriasis treatment: Tacrolimus ointment and pimecrolimus cream. aad.org
- Malecic N, Young H. Tacrolimus for the management of psoriasis: clinical utility and place in therapy. Psoriasis: Targets and Therapy, 2016;6:153–163 (review; we read nearly all of the text). pmc.ncbi.nlm.nih.gov
- Dermatology Times. Dermavant shares positive phase 4 data for tapinarof 1% in adults with plaque psoriasis of the head and neck. December 7, 2023 (news report of a sponsor announcement; the paper was not opened). dermatologytimes.com
- Dermatology Times. Investigational topical shows strong results for intertriginous psoriatic areas. August 19, 2020 (news report of a sponsor-run phase 2b trial published in the New England Journal of Medicine; the paper was not opened; older than the usual window). dermatologytimes.com
- WebMD. T/Gel shampoo: uses, side effects and warnings. Product information page for a coal tar shampoo, not Nopsor's label. webmd.com
- Djokic-Gallagher J, Rosher P, Hart V, Walker J. Steroid-sparing effects and acceptability of a new skin gel containing the anti-inflammatory medicinal substance nicotinamide. Clinical, Cosmetic and Investigational Dermatology, 2019;12:545–552 (authors employed by the gel's maker; mixed skin conditions). pmc.ncbi.nlm.nih.gov
- American Academy of Dermatology. Psoriasis: skin care tips. aad.org
- American Academy of Dermatology. How do I know if I'm using the right sunscreen?. aad.org
- Alexis AF, et al. Long-term safety and efficacy of roflumilast foam 0.3% in patients with seborrheic dermatitis: a phase II, open-label trial of up to 52 weeks. American Journal of Clinical Dermatology, 2026;27:189–198 (published online November 2025; funded by Arcutis, several authors are company employees; seborrheic dermatitis, not psoriasis). springer.com
This article is for educational purposes only and does not replace medical advice. Only a doctor can diagnose a skin condition and recommend treatment.